New Delhi, IAS. Indian Council of Medical Research (ICMR) Director General Dr. Balram Bhargava said on Tuesday that the development of India’s indigenous anti-corona vaccine vaccine is a perfect example of public-private partnership marked with trust and transparency. Dr. Bhargava was speaking at the launch of his book ‘Going Viral’. He said that the development of covaccine was possible only due to the cooperation between Bharat Biotech and ICMR.

In ‘Going Viral’, Dr. Bhargava has written the story of the development of the vaccine from the first case of corona infection in India. He has not only written about the difficulties faced in the journey from the development of the vaccine to its trial, but also mentioned the success achieved by the government and scientists together. In his book, he shares his experiences related to developing an indigenous anti-corona vaccine in a record time of eight months. He said that it will be important to protect our environment to prevent such epidemics in future.

Dr. Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS) Delhi, on the occasion of the book launch, said that the third wave of Kovid is not expected in the country with the same intensity as compared to the first two waves. He said that at this time there is no increase in infection cases indicating that vaccines still provide protection against the virus and at present there is no need for a third booster dose. Dr. Guleria said that the way vaccines are proving effective in preventing the severity of infection and preventing hospitalization, there is a possibility of a big wave including large number of people being admitted to hospitals every day. is getting weaker.

Edited By: Monika Minal